rs139580877

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_024867.4(SPEF2):​c.1262G>A​(p.Arg421His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0116 in 1,612,356 control chromosomes in the GnomAD database, including 139 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0072 ( 2 hom., cov: 33)
Exomes 𝑓: 0.012 ( 137 hom. )

Consequence

SPEF2
NM_024867.4 missense

Scores

6
12

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:1

Conservation

PhyloP100: 3.37

Publications

12 publications found
Variant links:
Genes affected
SPEF2 (HGNC:26293): (sperm flagellar 2) Involved in sperm axoneme assembly. Located in sperm flagellum. Implicated in spermatogenic failure 43. [provided by Alliance of Genome Resources, Apr 2022]
SPEF2 Gene-Disease associations (from GenCC):
  • spermatogenic failure 43
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: Ambry Genetics, PanelApp Australia, Labcorp Genetics (formerly Invitae)
  • primary ciliary dyskinesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • non-syndromic male infertility due to sperm motility disorder
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0092085).
BP6
Variant 5-35667166-G-A is Benign according to our data. Variant chr5-35667166-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 403482.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.00724 (1102/152298) while in subpopulation SAS AF = 0.0141 (68/4826). AF 95% confidence interval is 0.0114. There are 2 homozygotes in GnomAd4. There are 517 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 2 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SPEF2NM_024867.4 linkc.1262G>A p.Arg421His missense_variant Exon 9 of 37 ENST00000356031.8 NP_079143.3 Q9C093-1A0A140VKD0

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SPEF2ENST00000356031.8 linkc.1262G>A p.Arg421His missense_variant Exon 9 of 37 1 NM_024867.4 ENSP00000348314.3 Q9C093-1

Frequencies

GnomAD3 genomes
AF:
0.00725
AC:
1103
AN:
152180
Hom.:
2
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00220
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00426
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00135
Gnomad SAS
AF:
0.0143
Gnomad FIN
AF:
0.00348
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.0120
Gnomad OTH
AF:
0.00955
GnomAD2 exomes
AF:
0.00768
AC:
1917
AN:
249766
AF XY:
0.00838
show subpopulations
Gnomad AFR exome
AF:
0.00272
Gnomad AMR exome
AF:
0.00296
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00136
Gnomad FIN exome
AF:
0.00361
Gnomad NFE exome
AF:
0.0110
Gnomad OTH exome
AF:
0.00691
GnomAD4 exome
AF:
0.0121
AC:
17631
AN:
1460058
Hom.:
137
Cov.:
31
AF XY:
0.0122
AC XY:
8847
AN XY:
726176
show subpopulations
African (AFR)
AF:
0.00186
AC:
62
AN:
33404
American (AMR)
AF:
0.00350
AC:
156
AN:
44508
Ashkenazi Jewish (ASJ)
AF:
0.000153
AC:
4
AN:
26086
East Asian (EAS)
AF:
0.00172
AC:
68
AN:
39608
South Asian (SAS)
AF:
0.0132
AC:
1132
AN:
85808
European-Finnish (FIN)
AF:
0.00414
AC:
221
AN:
53386
Middle Eastern (MID)
AF:
0.00579
AC:
33
AN:
5702
European-Non Finnish (NFE)
AF:
0.0138
AC:
15316
AN:
1111236
Other (OTH)
AF:
0.0106
AC:
639
AN:
60320
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.489
Heterozygous variant carriers
0
916
1832
2749
3665
4581
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
588
1176
1764
2352
2940
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00724
AC:
1102
AN:
152298
Hom.:
2
Cov.:
33
AF XY:
0.00694
AC XY:
517
AN XY:
74476
show subpopulations
African (AFR)
AF:
0.00219
AC:
91
AN:
41572
American (AMR)
AF:
0.00425
AC:
65
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3464
East Asian (EAS)
AF:
0.00135
AC:
7
AN:
5186
South Asian (SAS)
AF:
0.0141
AC:
68
AN:
4826
European-Finnish (FIN)
AF:
0.00348
AC:
37
AN:
10618
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.0120
AC:
813
AN:
68020
Other (OTH)
AF:
0.00945
AC:
20
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
56
113
169
226
282
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00932
Hom.:
13
Bravo
AF:
0.00724
TwinsUK
AF:
0.0132
AC:
49
ALSPAC
AF:
0.0143
AC:
55
ESP6500AA
AF:
0.00340
AC:
15
ESP6500EA
AF:
0.0136
AC:
117
ExAC
AF:
0.00777
AC:
943
Asia WGS
AF:
0.00433
AC:
15
AN:
3476
EpiCase
AF:
0.0107
EpiControl
AF:
0.0110

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Oct 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

SPEF2: BP4, BS1, BS2 -

not specified Uncertain:1
Mar 29, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Candidate PCD gene, but frequency is high -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.099
BayesDel_addAF
Benign
-0.60
T
BayesDel_noAF
Benign
-0.62
CADD
Benign
22
DANN
Uncertain
1.0
DEOGEN2
Benign
0.14
.;.;T;D;.
Eigen
Benign
0.039
Eigen_PC
Benign
-0.048
FATHMM_MKL
Uncertain
0.90
D
LIST_S2
Benign
0.70
T;T;T;T;T
MetaRNN
Benign
0.0092
T;T;T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Uncertain
2.8
M;.;.;M;M
PhyloP100
3.4
PrimateAI
Benign
0.29
T
PROVEAN
Uncertain
-4.0
D;D;.;D;D
REVEL
Benign
0.16
Sift
Uncertain
0.0080
D;D;.;D;D
Sift4G
Uncertain
0.0070
D;D;.;D;D
Polyphen
1.0
D;D;.;D;.
Vest4
0.18
MVP
0.49
MPC
0.056
ClinPred
0.044
T
GERP RS
2.0
Varity_R
0.083
gMVP
0.33
Mutation Taster
=92/8
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs139580877; hg19: chr5-35667268; COSMIC: COSV99030946; API